Navigation Links
XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development
Date:6/11/2009

Outstanding team leader with a strong record of revenue growth and sales force development

DENVER, June 11 /PRNewswire-FirstCall/ -- XELR8 Holdings, Inc. (OTC Bulletin Board: XELR), a provider of functional foods, beverages and nutritional supplements, announced today that it has hired Kevin Sherman for the role of Vice President - Strategy and Network Development.

Sandy Greenberg, Chairman and CEO of XELR8 said, "We are excited to add Kevin's strong leadership and commitment to success to the XELR8 team. His experience in recruiting network partners, as well as implementing advanced sales training programs will have an immediate positive impact on the company's operations."

Prior to joining XELR8 Mr. Sherman achieved an impressive record of revenue enhancement and organizational development, most recently as Senior Manager - Network Development for the "Team Beachbody" division of Product Partners, LLC. Product Partners was listed in Entrepreneur Magazine's 500 Fastest Growing Businesses in America with current sales over $300 million a year.

Mr. Sherman, along with his team at Product Partners, implemented various strategies and initiatives that drove two-fold growth in distributors in under a year's time. During his tenure he oversaw exponential growth in revenue and built a culture committed to excellence. It is this relentless commitment to excellence and growth that he now brings to XELR8 as the Vice President of Strategy and Network Development.

Mr. Sherman added, "I am convinced that XELR8 is destined to be the premier direct selling company in America. XELR8 possesses all of the key components required to act as a strong partner for the many individual distributors and customers who are facing uncertain economic times and a concern for their health. In the coming months we expect our continued focus on sales training and marketing materials to have a dramatic impact on both the company's sales and the success of our distributors. I look forward to sharing my commitment to excellence and integrity with the current team at XELR8."

About XELR8 Holdings, Inc.

XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. XELR8's primary product is Bazi(TM), a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube, the South American Acai Berry, Blueberries and Raspberries plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, great tasting one-ounce shot.

XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott, Lawyer Milloy and former Head Coach Mike Shanahan; professional football superstars Brian Griese and Marco Rivera; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. Additionally, XELR8 has collaboration agreements with both the renowned Steadman Hawkins Clinic and the Greenville Hospital System of South Carolina. XELR8 products are only available through independent distributors located throughout the nation. For more information about XELR8, please visit www.xelr8.com or www.drinkbazi.com.

Safe Harbor

Except for the historical information contained herein, the matters set forth in this press release, including the description of the company and its products offerings, are forward-looking statements within the meaning of the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the historical volatility and low trading volume of our stock, the risk and uncertainties inherent in the early stages of growth companies, the company's need to raise substantial additional capital to proceed with its business, risks associated with competitors, and other risks detailed from time to time in the company's most recent filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements.

        Investor Relations
        David Elias
        516-967-0205


'/>"/>
SOURCE XELR8 Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007
2. XELR8 Holdings Announces Fiscal 2007 Financial Results
3. XELR8 Holdings Announces Record First Quarter Revenue
4. XELR8 Holdings Announces Continuation of XELR8 To A Million Promotion
5. XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results
6. XELR8 Holdings, Inc. Announces Fourth Quarter and 2008 Annual Financial Results
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
9. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
10. Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 2007
11. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... ... , ... Shark Finds and Kevin Harrington, along with the Product ... with Belly Bands. , Having a dog is great—except when it wets every couch, ... nothing works, get Belly Bands, the easiest way to stop dogs from wetting ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 ... ... today announced the availability of the company's lighter, sleeker next generation LYNX VR ... assembly plant. , Improvements in design and manufacturing not only reduce the ...
(Date:2/5/2016)... FL (PRWEB) , ... February 05, 2016 , ... ... the largest domestic franchisees of Popeyes Louisiana Kitchen restaurants, launched the 14th annual ... awareness for kids and adults with muscular dystrophy, ALS and related diseases that ...
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active staff surgeon and ... cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division of Plastic Surgery ... three-year term as chief and began a second three-year term in January of 2016. ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... -- As people age, it is natural to be more ... tests that are linked with certain age milestones simplify ... of aging individuals, hearing health is too frequently left ... American adults who report some trouble hearing, there is ... a 2016 healthy aging priority.[1] Cochlear ...
(Date:2/5/2016)... 5, 2016 ... the "Global Musculoskeletal Partnering 2010-2016: Deal ... to their offering. --> ... the "Global Musculoskeletal Partnering 2010-2016: Deal ... to their offering. --> ...
(Date:2/5/2016)... --> --> ... the global active pharmaceuticals ingredients (APIs) market stood at ... US$185.9 bn by 2020. It is expected to expand ... The title of the report is "Active Pharmaceutical Ingredients ... by Therapeutic Area) - Global Industry Analysis, Size, Share, ...
Breaking Medicine Technology: